This analysis revealed that the low SMARCA2 gene expression did not correlate with clinical stage of the disease (Figure 3a) but we found a strong correlation between low SMARCA2 transcript level and BC metastasis p‐value < .0001 (Figure 3b). The gene discussed is SMARCA2; the disease is breast cancer.